# Version Reconciliation Summary

## ðŸš¨ CRITICAL DISCOVERY

**The V3 results are completely different from V1/V2 because V3 was using hardcoded placeholder data instead of actual economic calculations.**

### Root Cause Identified

1. **V3 Implementation**: Uses static, hardcoded values in CLI modules
2. **V2 Implementation**: Uses actual Markov model with Monte Carlo simulation  
3. **Data Disconnect**: V3 never connected to the validated input datasets

### Key Differences Explained

| Aspect | V2 (Actual) | V3 (Placeholder) | Reason |
|--------|-------------|------------------|---------|
| Most cost-effective | PO-KA (Oral ketamine) | PO psilocybin | V3 used arbitrary rankings |
| Cost range | $1,000-$15,000+ | $800-$1,200 | V3 used simplified test values |  
| QALY range | 2.0-2.4+ | 0.75-0.85 | V3 used placeholder utilities |
| Uncertainty | Real PSA variance | Artificial distributions | V3 simulated fake uncertainty |

### Actions Taken

1. âœ… **Identified V3 implementation errors**
2. âœ… **Created comprehensive analysis report** 
3. âœ… **Generated comparison visualizations** (with caveats)
4. âœ… **Documented all discrepancies and root causes**

### Recommendations

- **IMMEDIATE**: Use V2 results for any decisions or publications
- **V3 STATUS**: Invalid until corrected to use actual calculations
- **NEXT STEPS**: Fix V3 to integrate with existing validated data pipeline

---

**The V3 plots and analysis were successfully created, but they represent placeholder data patterns rather than actual economic evaluation results.**